NIH: Alzheimer’s Disease Sequencing Project (ADSP) Replication Phase Analysis Studies (U01) – RFA-AG-16-002:

The ultimate aim of this opportunity is to identify the genomic contributions to both risk for AD and protection against AD, and the correlations between human genetic variation and the relationship to health and disease. Under the award, the investigator(s) will generate Replication phase data and lead comprehensive analyses of the targeted sequence data along with genotype data to replicate and validate data generated in the Discovery Phase of the ADSP and provide these data to the awardees of the companion FOA for harmonization and joint/meta-analysis of ADSP data as a whole. The direct cost limit in the first year is $600,000. Total costs across the remaining years are limited to $1.3 million with no more than $500,000 in any single year; project period limit 5 years.

http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-16-002.html